MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2024 International Congress

    The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings

    R. Kumar, A. Kanojia (Darbhanga, India)

    Objective: Our research sought to unravel the pharmacological effects and mechanisms of action of Rolipram through both in vivo and in vitro experimentation in models…
  • 2024 International Congress

    Neuroprotective Efficacy of Ethanolic Extract from Amorphophallus Paeoniifolius Tuber Against Haloperidol-Induced Parkinson’s Disease Model

    R. Kumar, S. Choudhary (Handia,, India)

    Objective: This study aimed to evaluate the neuroprotective and antiparkinsonian effects of the ethanolic extract of Amorphophallus paeoniifolius tuber (APT) against haloperidol-induced Parkinson’s Disease (PD)…
  • 2024 International Congress

    Gender Disparities in Quality of Life Domains Among Hispanic Individuals with Parkinson’s Disease: A Comparative Analysis

    D. Bustamante-Mieles, C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: This study aims to determine gender differences in the quality of life of Parkinson's disease (PD) among Hispanic individuals. Background: PD profoundly affects various…
  • 2024 International Congress

    Visual Temporal Discrimination Threshold using a Virtual Reality Paradigm in Cervical Dystonia

    SR. Bostan, B. Lim, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: To develop a Virtual Reality (VR) application to test temporal discrimination thresholds in cervical dystonia patients within an outpatient environment. Background: Temporal discrimination threshold…
  • 2024 International Congress

    Dysfluent Writing Behavior Associates with Reduced Striatal-cerebellar Connectivity in Writer’s Cramp Dystonia

    Z. Simsek, M. Lipp, S. Groves, Z. Huang, M. Fei, J. Voyvodic, C. Petty, M. Lutz, N. Bukhari-Parlakturk (Durham, USA)

    Objective: The primary objective of this study was to identify the brain regions contributing to dysfluent writing behavior in a subtype of dystonia called writer’s…
  • 2024 International Congress

    Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

    A. Kumar, P. Mishra (Delhi, India)

    Objective: Our objective is to estimate the level of Hcy ,vitamin B12 , folic acid with motor and non-motor symptoms in HD patients in school…
  • 2023 International Congress

    Tramadol Induces Neuroinflammation, Mitochondrial Oxidative Stress, Neurotransmitters Dysbalanced and Produced Parkinson’s Disease Like Symptoms in Experimental Wistar Rats

    KHA. Aran (Moga, India)

    Objective: The current study is designed to evaluate the possible neurotoxic effects of tramadol in Wistar rats. Background: Parkinson’s disease (PD) is a chronic neurodegenerative…
  • 2023 International Congress

    Specific Parkinson’s disease phenotype in patients with long term PTSP

    I. šarac, H. šarac, N. Henigsberg, F. Borovečki, Z. Krešić, I. Ivek, T. Sukobljević (Zagreb, Croatia)

    Objective: to describe possibly specific clinical phenotype of PD patients who suffered from long-term postraumatic-stress-disorders (PTSD Background: There is enough evidence about the relationship between…
  • 2023 International Congress

    Diffusion imaging study of mild behavioral impairment in Parkinson’s disease.

    H. Almgren, M. Descoteaux, M. Ghahremani, Z. Ismail, O. Monchi (Calgary, Canada)

    Objective: Patients with Parkinson’s disease (PD) experience changes in behavior, personality, and cognition. Mild Behavioral Impairment (MBI) is a validated neurobehavioral syndrome that identifies a…
  • 2023 International Congress

    Therapeutic effects of citral nanoliposome on Parkinson’s treatment in a rat model: Modulation via neurochemical, inflammatory and antioxidant pathways

    N. Moradikor, M. Haghipanah, W. Mohamed (Tbilisi, Georgia)

    Objective: The present study aimed to assess the effects of citral nanoliposome on Parkinson's treatment in a rat model. Background: Parkinson's disease is the most…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley